Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.6201
-0.0356 (-5.43%)
At close: Feb 4, 2026, 4:00 PM EST
0.6300
+0.0099 (1.60%)
After-hours: Feb 4, 2026, 5:51 PM EST
Immunic Market Cap
Immunic has a market cap or net worth of $74.59 million as of February 4, 2026. Its market cap has decreased by -13.11% in one year.
Market Cap
74.59M
Enterprise Value
41.16M
1-Year Change
-13.11%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $74.59M, a decrease of -69.38%. That is a compound annual growth rate of -15.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 78.87M | 22.86% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OKYO Pharma | 80.75M |
| MediciNova | 80.60M |
| PolyPid | 78.85M |
| Biomea Fusion | 78.48M |
| Adicet Bio | 77.82M |
| Coeptis Therapeutics Holdings | 77.59M |
| MAIA Biotechnology | 76.53M |
| ImageneBio | 74.98M |